Relay Therapeutics, Inc. Contracts & Agreements

Underwriting Agreement, dated as of September 10, 2024, by and among the Company, Goldman Sachs & Co. LLC and TD Securities (USA) LLC, as representatives of the several... (Filed With SEC on September 11, 2024)

Description of Securities (Filed With SEC on February 22, 2024)

Securities Purchase Agreement, dated as of January 8, 2024, among Relay Therapeutics, Inc. and the purchaser party thereto (Filed With SEC on January 8, 2024)

Amendment No. AR5 to Amended and Restated Collaboration and License Agreement, by and between the Registrant and D.E. Shaw Research, LLC, dated August 4, 2023 (Filed With SEC on November 2, 2023)

Amendment No. AR4 to Amended and Restated Collaboration and License Agreement, by and between the Registrant and D.E. Shaw Research, LLC, dated March 22, 2023 (Filed With SEC on August 8, 2023)

Amended and Restated Non-Employee Director Compensation Policy, effective as of June 1, 2023 (Filed With SEC on August 8, 2023)

Retention Agreement by and between the Registrant and Peter Rahmer, dated August 3, 2023 (Filed With SEC on August 8, 2023)

Underwriting Agreement, dated as of September 12, 2022, by and among the Company, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC, as... (Filed With SEC on September 15, 2022)

2020 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on February 24, 2022)

Underwriting Agreement, dated as of October 12, 2021, by and among the Company, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Cowen and Company, LLC and Guggenheim... (Filed With SEC on October 14, 2021)

Retention Agreement by and between the Registrant and Donald Bergstrom, dated May 10, 2021 (Filed With SEC on August 12, 2021)

Retention Agreement by and between the Registrant and Donald Bergstrom, dated May 10, 2021 (Filed With SEC on May 13, 2021)

Amendment No. 2 to Amended and Restated Collaboration and License Agreement, by and between the Registrant and D. E. Shaw Research, LLC, dated May 12, 2021 (Filed With SEC on May 13, 2021)

Amended and Restated Non-Employee Director Compensation Policy, effective as of April 1, 2021 (Filed With SEC on April 28, 2021)

Amendment No. 1 to Amended and Restated Collaboration and License Agreement, by and between the Registrant and D. E. Shaw Research, LLC, dated February 4, 2021 (Filed With SEC on April 28, 2021)

Registration Rights Agreement by and between the Registrant and the stockholders of ZebiAI Therapeutics, Inc. dated April 22, 2021 (Filed With SEC on April 28, 2021)

Agreement and Plan of Merger, dated as of April 15, 2021, by and among Relay Therapeutics, Inc., Elixir Merger Sub I, Inc., Elixir Merger Sub II, LLC, ZebiAI Therapeutics, Inc.... (Filed With SEC on April 16, 2021)

Description of Securities (Filed With SEC on March 25, 2021)

Second Amendment to Lease, dated as of September 23, 2020, between the Registrant and ARE-MA REGION NO. 58, LLC (Filed With SEC on November 12, 2020)

Form of Underwriting Agreement (Filed With SEC on July 9, 2020)

Specimen Common Stock Certificate (Filed With SEC on July 9, 2020)

Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of December 19, 2018 as amended on June 26, 2020 (Filed With SEC on July 9, 2020)

2020 Stock Option and Grant Plan, and form of award agreements thereunder (Filed With SEC on July 9, 2020)

2020 Employee Stock Purchase Plan (Filed With SEC on July 9, 2020)

Non-Employee Director Compensation Policy (Filed With SEC on July 9, 2020)

Form of Amended and Restated Employment Agreement (Filed With SEC on July 9, 2020)

Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of December 19, 2018 (Filed With SEC on June 24, 2020)

2016 Stock Option and Grant Plan, and form of award agreements thereunder (Filed With SEC on June 24, 2020)

Senior Executive Cash Bonus Plan (Filed With SEC on June 24, 2020)

Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on June 24, 2020)

Category

Industry

Companies

Contracts

Relay Therapeutics, Inc. Contracts & Agreements